{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Milwaukee&page=30&state=Wisconsin", "query": { "state": "Wisconsin", "city": "Milwaukee", "page": 30 }, "page_size": 10 }, "pagination": { "page": 30, "page_size": 10, "total_count": 5349, "total_pages": 535, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Milwaukee&page=31&state=Wisconsin&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Milwaukee&page=29&state=Wisconsin&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T00:50:49.752Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05875168", "title": "First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Tumor", "Metastatic Solid Tumor" ], "interventions": [ { "name": "DS-3939a", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 590, "start_date": "2023-08-18", "completion_date": "2028-11-11", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 12, "location_summary": "Sarasota, Florida • Locust Grove, Georgia • Westwood, Kansas + 9 more", "locations": [ { "city": "Sarasota", "state": "Florida" }, { "city": "Locust Grove", "state": "Georgia" }, { "city": "Westwood", "state": "Kansas" }, { "city": "Detroit", "state": "Michigan" }, { "city": "East Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05875168" }, { "nct_id": "NCT01226420", "title": "Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Graft-versus-host Disease" ], "interventions": [ { "name": "Alefacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2010-10", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2013-08-13", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 3, "location_summary": "Boston, Massachusetts • Seattle, Washington • Milwaukee, Wisconsin", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Seattle", "state": "Washington" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01226420" }, { "nct_id": "NCT04477759", "title": "Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Head and Neck Neoplasm" ], "interventions": [ { "name": "50 Gy Radiation Therapy", "type": "RADIATION" }, { "name": "55 Gy Radiation Therapy", "type": "RADIATION" }, { "name": "60 Gy Radiation Therapy", "type": "RADIATION" }, { "name": "Concurrent Atezolizumab", "type": "DRUG" }, { "name": "Adjuvant Atezolizumab", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2021-01-26", "completion_date": "2025-04-14", "has_results": true, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04477759" }, { "nct_id": "NCT01586910", "title": "Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Severe Aortic Stenosis" ], "interventions": [ { "name": "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)", "type": "DEVICE" }, { "name": "Surgical Aortic Valve Replacement (SAVR)", "type": "PROCEDURE" }, { "name": "Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Medtronic Cardiovascular", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1746, "start_date": "2012-04", "completion_date": "2026-11", "has_results": true, "last_update_posted_date": "2026-06-24", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 65, "location_summary": "Phoenix, Arizona • Hollywood, California • La Jolla, California + 55 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hollywood", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mountain View", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01586910" }, { "nct_id": "NCT06052059", "title": "A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "IV Tulisokibart", "type": "DRUG" }, { "name": "IV Placebo", "type": "DRUG" }, { "name": "SC Tulisokibart", "type": "DRUG" }, { "name": "SC Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 1109, "start_date": "2023-10-25", "completion_date": "2029-08-01", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 76, "location_summary": "Dothan, Alabama • Fairhope, Alabama • Litchfield Park, Arizona + 65 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06052059" }, { "nct_id": "NCT01458574", "title": "A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "CP690,550", "type": "DRUG" }, { "name": "CP-690,550", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 593, "start_date": "2012-07-20", "completion_date": "2016-05-27", "has_results": true, "last_update_posted_date": "2017-05-18", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 94, "location_summary": "Mobile, Alabama • La Jolla, California • Oceanside, California + 47 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01458574" }, { "nct_id": "NCT00382018", "title": "S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "chemotherapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 624, "start_date": "2006-10", "completion_date": "2017-07-11", "has_results": true, "last_update_posted_date": "2017-11-06", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 296, "location_summary": "Anniston, Alabama • Anchorage, Alaska • Jonesboro, Arkansas + 210 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00382018" }, { "nct_id": "NCT03266640", "title": "Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cytomegalovirus Infections", "Primary Immune Deficiency Disorder" ], "interventions": [ { "name": "viral specific cytotoxic t-lymphocytes", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York Medical College", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "79 Years", "sex": "ALL", "summary": "1 Month to 79 Years" }, "enrollment_count": 20, "start_date": "2018-11-01", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2025-08-08", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 9, "location_summary": "Los Angeles, California • San Francisco, California • Indianapolis, Indiana + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03266640" }, { "nct_id": "NCT00016523", "title": "Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infant, Newborn", "Infant, Low Birth Weight", "Infant, Small for Gestational Age", "Infant, Premature", "Respiratory Distress Syndrome (RDS)", "Sepsis", "Pneumonia", "Hypertension, Pulmonary" ], "interventions": [ { "name": "Inhaled nitric oxide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NICHD Neonatal Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "120 Hours", "sex": "ALL", "summary": "Up to 120 Hours" }, "enrollment_count": 420, "start_date": "2001-01", "completion_date": "2006-05", "has_results": false, "last_update_posted_date": "2017-09-26", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Palo Alto, California • San Diego, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00016523" }, { "nct_id": "NCT00437060", "title": "Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Childhood B Acute Lymphoblastic Leukemia", "Childhood T Acute Lymphoblastic Leukemia", "Cognitive Side Effects of Cancer Therapy", "Long-Term Effects Secondary to Cancer Therapy in Children", "Neurotoxicity Syndrome", "Psychological Impact of Cancer", "Untreated Childhood Acute Lymphoblastic Leukemia" ], "interventions": [ { "name": "Cognitive Assessment", "type": "PROCEDURE" }, { "name": "Diffusion Tensor Imaging", "type": "PROCEDURE" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Pharmacological Study", "type": "OTHER" }, { "name": "Psychosocial Assessment and Care", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "17 Years", "sex": "ALL", "summary": "1 Year to 17 Years" }, "enrollment_count": 233, "start_date": "2007-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-07-21", "last_synced_at": "2026-10-23T00:50:49.752Z", "location_count": 102, "location_summary": "Birmingham, Alabama • Downey, California • Long Beach, California + 83 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Downey", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00437060" } ] }